Jury Consults Defense Testimony In Martoma Case

Feb 6 2014 | 11:49am ET

Is former SAC Capital Advisors portfolio manager Mathew Martoma about to break prosecutors' perfect record in the government's insider-trading crackdown?

The jury is still out, having deliberated for a second day without reaching a verdict. But the panel requested testimony yesterday that could be a sign it is leaning towards finding him "not guilty."

The jury yesterday asked to see the transcript of Thomas Wisniewski's time on the stand. Wisniewski, a New York University medical professor who testified for the defense, said that he saw "no substantial difference" between the allegedly insider information about a drug test results and a press-release issued by the two drug companies Martoma is accused of illegally trading.

If the jury believes that the information was already publicly available, it cannot convict Martoma. That would be a first: Prosecutors have won 78 convictions or guilty pleas in insider-trading cases in recent years, against zero acquittals.

The jury resumed its deliberations today.


In Depth

Fundraising for Mid-Sized PE Funds: Should You Use a Registered B/D?

Dec 6 2016 | 7:18pm ET

When does a fund sponsor need to use a registered broker/dealer when raising capital...

Lifestyle

Trump Attends 'Villains and Heroes' Costume Party Dressed As...Himself

Dec 5 2016 | 11:16pm ET

U.S. President-elect Donald Trump attended a "Villains and Heroes" costume party...

Guest Contributor

A Hard Look At Your ‘Soft’ Hedge Fund Marketing Information

Dec 8 2016 | 9:03pm ET

Conventional wisdom holds that due diligence examines quantitative as well as qualitative...

 

From the current issue of

Since the inception of Modern Trader, a core editorial theme has centered on the wisdom and power of crowds. Editorial emphasis has focused on companies and projects engaged in the collection and analysis of information. 

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR